Drug
Hiv Integrase Inhibitor
Hiv Integrase Inhibitor: highest development phase Phase 2, developed by Bristol-Myers Squibb. 1 trial record tracked on RxWires.
- Highest phase
- Phase 2
- Developer
- Bristol-Myers Squibb
Trials
| Drug | Phase | Indication |
|---|---|---|
| HIV Integrase Inhibitor (BMS-707035) NCT00397566 | Phase 2 | HIV Infections |
Latest
No recent events.
Follow Hiv Integrase Inhibitor on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.